AGL

In November 2025, Agilon Health received a notice from the NYSE regarding non-compliance with continued listing standards due to its stock price falling below $1.00 for 30 consecutive trading days, and anticipated pursuing a reverse stock split. In May 2026, the stock experienced a substantial rally following a strong Q1 2026 earnings report, beating analyst expectations, and management raised its full-year 2026 guidance. The stock price more than doubled in a single trading session on May 7, 2026, but had experienced a significant decline of 67.14% between May 7, 2025, and May 6, 2026.